About
OptoRhythm is developing a novel light-based method for controlling heart rhythms. Built on over 20 years of research by Prof. Lior Gepstein, a leader in cardiac electrophysiology and optogenetics, OptoRhythm’s approach aims to improve treatment for Atrial Fibrillation (AF). The technology integrates optogenetic gene therapy with an implantable micro-LED array to create the first Optic Defibrillator, designed to stop chaotic atrial contractions through targeted light pulses, offering an alternative to traditional electric shocks. This real-time, repeatable, and non-destructive approach addresses limitations in existing AF treatments, aiming for sustained rhythm control and improved patient outcomes.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Optorhythm's core technology?
- Optorhythm is developing an optogenetic therapy for Atrial Fibrillation (AF) using an implantable micro-LED array to deliver targeted light pulses, functioning as an 'Optic Defibrillator'.
- When was Optorhythm founded?
- Optorhythm was founded in August 2024.
- What is the current status of Optorhythm?
- Optorhythm is currently inactive, having ceased operations in July 2025.
- Who is the founder of Optorhythm?
- Yaki Eidelstein is listed as a founder of Optorhythm.
- What was Optorhythm's last funding round?
- Optorhythm's last funding round was a Pre-Seed round in September 2024, with NGT HealthCare II as an investor.
- What is the primary sector of Optorhythm?
- Optorhythm's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- What is the employee count for Optorhythm?
- Optorhythm has 1 employee.
- What problem does Optorhythm's technology aim to solve?
- Optorhythm's technology aims to improve treatment for Atrial Fibrillation (AF) by offering a real-time, repeatable, and non-destructive alternative to traditional electric shocks for stopping chaotic atrial contractions.